Analysis of the Dynamics of Infiltrating CD4+ T Cell Subsets in the Heart during Experimental Trypanosoma cruzi Infection

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sanoja, Cristina ^a   Carbajosa, Sofía ^b   Fresno, Manuel ^b,c   Gironès, Núria ^b,c  

^a FACULTAD DE CIENCIAS   (Venezuela)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEART; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; LETHALITY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PARASITE LOAD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH17 CELL; TRYPANOSOMA CRUZI;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; CYTOKINES; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; INTERFERON-GAMMA; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA CRUZI;

MUS; PROTOZOA; TRYPANOSOMA CRUZI;

EID: 84878898554     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065820     Document Type: Article

References (46)

1. Telleria J, Tibayrenc M (2010) American Trypanosomiasis. Chagas Disease: One hundred years of research. Elsevier: 848.
2. Girones N, Fresno M, (2003) Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both? Trends Parasitol 19: 19-22.
3. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV, (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-1123.
4. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A, (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22: 2501-2506.
5. Munoz-Fernandez MA, Fernandez MA, Fresno M, (1992) Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 22: 301-307.
6. Aliberti JC, Souto JT, Marino AP, Lannes-Vieira J, Teixeira MM, et al. (2001) Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 158: 1433-1440.
7. Holscher C, Kohler G, Muller U, Mossmann H, Schaub GA, et al. (1998) Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 66: 1208-1215.
8. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M, (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
9. Jager A, Kuchroo VK, (2010) Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 72: 173-184.
10. Yamaguchi T, Hirota K, Nagahama K, Ohkawa K, Takahashi T, et al. (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27: 145-159.
11. Stephens LA, Mason D, (2000) CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. J Immunol 165: 3105-3110.
12. Wynn TA, (2005) T(H)-17: a giant step from T(H)1 and T(H)2. Nat Immunol 6: 1069-1070.
13. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
14. Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, et al. (2007) Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci 12: 2797-2806.
15. de Araujo FF, Vitelli-Avelar DM, Teixeira-Carvalho A, Antas PR, Assis Silva Gomes J, et al. (2011) Regulatory T cells phenotype in different clinical forms of Chagas' disease. PLoS Negl Trop Dis 5: e992.
16. Vitelli-Avelar DM, Sathler-Avelar R, Dias JC, Pascoal VP, Teixeira-Carvalho A, et al. (2005) Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes. Scand J Immunol 62: 297-308.
17. Kotner J, Tarleton R, (2007) Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect Immun 75: 861-869.
18. Sales PA Jr, Golgher D, Oliveira RV, Vieira V, Arantes RM, et al. (2008) The regulatory CD4+CD25+ T cells have a limited role on pathogenesis of infection with Trypanosoma cruzi. Microbes Infect 10: 680-688.
19. Mariano FS, Gutierrez FR, Pavanelli WR, Milanezi CM, Cavassani KA, et al. (2008) The involvement of CD4+CD25+ T cells in the acute phase of Trypanosoma cruzi infection. Microbes Infect 10: 825-833.
20. Guedes PM, Gutierrez FR, Silva GK, Dellalibera-Joviliano R, Rodrigues GJ, et al. (2012) Deficient regulatory T cell activity and low frequency of IL-17-producing T cells correlate with the extent of cardiomyopathy in human Chagas' disease. PLoS Negl Trop Dis 6: e1630.
21. da Matta Guedes PM, Gutierrez FR, Maia FL, Milanezi CM, Silva GK, et al. (2010) IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis 4: e604.
22. Miyazaki Y, Hamano S, Wang S, Shimanoe Y, Iwakura Y, et al. (2010) IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection. J Immunol 185: 1150-1157.
23. Tosello Boari J, Amezcua Vesely MC, Bermejo DA, Ramello MC, Montes CL, et al. (2012) IL-17RA signaling reduces inflammation and mortality during Trypanosoma cruzi infection by recruiting suppressive IL-10-producing neutrophils. PLoS Pathog 8: e1002658.
24. Abrahamsohn IA, da Silva AP, Coffman RL, (2000) Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi. Infect Immun 68: 1975-1979.
25. de Meis J, Morrot A, Farias-de-Oliveira DA, Villa-Verde DM, Savino W, (2009) Differential regional immune response in Chagas disease. PLoS Negl Trop Dis 3: e417.
26. Savino W, (2006) The thymus is a common target organ in infectious diseases. PLoS Pathog 2: e62.
27. Girones N, Cuervo H, Fresno M, (2005) Trypanosoma cruzi-induced molecular mimicry and Chagas' disease. Curr Top Microbiol Immunol 296: 89-123.
28. Andrade LO, Machado CR, Chiari E, Pena SD, Macedo AM, (2002) Trypanosoma cruzi: role of host genetic background in the differential tissue distribution of parasite clonal populations. Exp Parasitol 100: 269-275.
29. Dutra WO, Menezes CA, Villani FN, da Costa GC, da Silveira AB, et al. (2009) Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Mem Inst Oswaldo Cruz 104Suppl 1: 208-218.
30. Trischmann TM, Bloom BR, (1982) Genetics of murine resistance to Trypanosoma cruzi. Infect Immun 35: 546-551.
31. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, et al. (2004) Frequency of interferon- gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189: 909-918.
32. Perez AR, Silva-Barbosa SD, Roggero E, Calmon-Hamaty F, Villar SR, et al. (2011) Immunoendocrinology of the thymus in Chagas disease. Neuroimmunomodulation 18: 328-338.
33. Agus DB, Surh CD, Sprent J, (1991) Reentry of T cells to the adult thymus is restricted to activated T cells. J Exp Med 173: 1039-1046.
34. Michie SA, Kirkpatrick EA, Rouse RV, (1988) Rare peripheral T cells migrate to and persist in normal mouse thymus. J Exp Med 168: 1929-1934.
35. Carrera-Silva EA, Carolina CR, Natalia G, Pilar AM, Andrea P, et al. (2008) TLR2, TLR4 and TLR9 are differentially modulated in liver lethally injured from BALB/c and C57BL/6 mice during Trypanosoma cruzi acute infection. Mol Immunol 45: 3580-3588.
36. Perez AR, Tamae-Kakazu M, Pascutti MF, Roggero E, Serra E, et al. (2005) Deficient control of Trypanosoma cruzi infection in C57BL/6 mice is related to a delayed specific IgG response and increased macrophage production of pro-inflammatory cytokines. Life Sci 77: 1945-1959.
37. Gao W, Pereira MA, (2002) Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi. Int J Parasitol 32: 167-170.
38. Andrade V, Barral-Netto M, Andrade SG, (1985) Patterns of resistance of inbred mice to Trypanosoma cruzi are determined by parasite strain. Braz J Med Biol Res 18: 499-506.
39. Cuervo H, Guerrero NA, Carbajosa S, Beschin A, De Baetselier P, et al. (2011) Myeloid-derived suppressor cells infiltrate the heart in acute Trypanosoma cruzi infection. J Immunol 187: 2656-2665.
40. Cuervo H, Pineda MA, Aoki MP, Gea S, Fresno M, et al. (2008) Inducible nitric oxide synthase and arginase expression in heart tissue during acute Trypanosoma cruzi infection in mice: arginase I is expressed in infiltrating CD68+ macrophages. J Infect Dis 197: 1772-1782.
41. Baldeviano GC, Barin JG, Talor MV, Srinivasan S, Bedja D, et al. (2010) Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ Res 106: 1646-1655.
42. Legault J, Baldeviano G, Barin J, Wu LO, S., Talor M, et al. (2012) IL6 is necessary for the progression of experimental autoimmune myocarditis to dilated cardiomyopathy. The Journal of Immunology 188: 11.
43. (1986) Council directive from the Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Strasbourg, France) 18 March.
44. Brener Z, (1962) Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo 4: 389-396.
45. Marcon GE, Andrade PD, de Albuquerque DM, Wanderley Jda S, de Almeida EA, et al. (2002) Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagn Microbiol Infect Dis 43: 39-43.
46. Piron M, Fisa R, Casamitjana N, Lopez-Chejade P, Puig L, et al. (2007) Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 103: 195-200.